Usui R, Yabe D, Seino Y
Understanding what to expect when starting a new medication, like GLP-1 medication for weight loss, is key to making informed health decisions
Methods: HBV transgenic (HBV-Tg) mice were intraperitoneally injected with CCl4 to construct a murine model of hepatitis B-related liver fibrosis
Disclosures: Ashish Bibireddy: Nothing to Disclose, Smruti Rath: Nothing to Disclose, Ishaan Dharia: Nothing to Disclose, Gene Im: KorroBio: Consultant, Echosens: Device support for research 1160 LONG-TERM VASCULAR OUTCOMES AND MORTALITY AFTER BARIATRIC SURGERY AMONG PATIENTS WITH OBESITY, TYPE 2 DIABETES, AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE Arunkumar Krishnan 1 Diptasree Mukherjee 2 Carolin Schneider 3 Tinsay Woreta 4 Saleh Alqahtani 5 , 1 Atrium Health Levine Cancer, 2 Apex Institute of Medical Sciences, Kolkata, WB, India, 3 RWTH Aachen University, Aachen, Germany, 4 Johns Hopkins University School of Medicine, 5 Johns Hopkins University Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes (T2D) frequently coexist and synergistically increase the risk of adverse clinical outcomes
And so you want to be careful about decreasing the loss of the skeletal muscle mass during weight loss
